Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA

Journal of Virology

Volumn 81, Issue 14, 2007, Pages 7351-7362

  Puro, Robyn ^a   Schneider, Robert J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; NITRIC OXIDE; TUMOR NECROSIS FACTOR; VIRUS DNA; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL LYSATE; CHICKEN; CONTROLLED STUDY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; LIVER CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METHYLATION; UBIQUITINATION; VIRUS IMMUNITY; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; CELL LINE; CELL NUCLEUS; DNA PRIMERS; DNA, VIRAL; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; IMMUNITY, NATURAL; NF-KAPPA B; NUCLEOCAPSID; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

ANIMALIA; DUCK HEPATITIS B VIRUS; HEPATITIS B VIRUS; RATTUS;

EID: 34447260029     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00554-07     Document Type: Article

References (71)

1. al-Wabel, A., M. al-Janadi, and S. Raziuddin. 1993. Cytokine profile of viral and autoimmune chronic active hepatitis. J. Allergy Clin. Immunol. 92:902-908.
2. Ando, K., L. G. Guidotti, S. Wirth, T. Ishikawa, G. Missale, T. Moriyama, R. D. Schreiber, H. J. Schlicht, S. N. Huang, and F. V. Chisari. 1994. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152:3245-3253.
3. Baron, J. L., L. Gardiner, S. Nishimura, K. Shinkai, R. Locksley, and D. Ganem. 2002. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16:583-594.
4. Barrasa, M. I., J. T. Guo, J. Saputelli, W. S. Mason, and C. Seeger. 2001. Does a cdc2 kinase-like recognition motif on the core protein of hepadnaviruses regulate assembly and disintegration of capsids? J. Virol. 75:2024-2028.
5. Biermer, M., R. Puro, and R. J. Schneider. 2003. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid integrity through activation of NF-κB. J. Virol. 77:4033-4042.
6. 1 transit via a Src kinase pathway. J. Virol. 75:4247-4257.
7. Bouchard, M. J., L. H. Wang, and R. J. Schneider. 2001. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 294:2376-2378.
8. Bozkaya, H., M. Bozdayi, R. Turkyilmaz, M. Sarioglu, H. Cetinkaya, K. Cinar, K. Kose, C. Yurdaydin, and O. Uzunalimoglu. 2000. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease. Hepatogastroenterology 47:1675-1679.
9. Cavanaugh, V. J., L. G. Guidotti, and F. V. Chisari. 1997. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J. Virol. 71:3236-3243.
10. Chen, G., and D. V. Goeddel. 2002. TNF-R1 signaling: a beautiful pathway. Science 296:1634-1635.
11. Dandri, M., and J. Petersen. 2005. Hepatitis B virus cccDNA clearance: killing for curing? Hepatology 42:1453-1455.
12. Daniels, H., A. Meager, A. W. F. L. Eddleston, G. J. M. Alexander, and R. Williams. 1990. Spontaneous TNF-alpha and IL-1beta production during successful interferon therapy in chronic HBV infection. Lancet 335:875-877.
13. Deres, K., C. H. Schroder, A. Paessens, S. Goldmann, H. J. Hacker, O. Weber, T. Kramer, U. Niewohner, U. Pleiss, J. Stoltefuss, E. Graef, D. Koletzki, R. N. Masantschek, A. Reimann, R. Jaeger, R. Grob, B. Beckermann, K. Schlemmer, D. Haebich, and H. Rübsamen-Waigmann. 2003. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 299:893-896.
14. Ganem, D., and R. J. Schneider. 2001. The molecular biology of the hepatitis B viruses, p. 2923-2970. In D. Knipe and P. Howley (ed.), Fields virology, 4th ed., vol. 2. Lippincott, New York, NY.
15. Garcia-Navarro, R., B. Blanco-Urgoiti, P. Berraondo, R. Sanchez de la Rosa, A. Vales, S. Hervas-Stubbs, J. J. Lasarte, F. Borras, J. Ruiz, and J. Prieto. 2001. Protection against woodchuck hepatitis virus (WHV) infection by gene gun coimmunization with WHV core and interleukin-12. J. Virol. 75:9068-9076.
16. Garcia-Ruiz, C., and J. C. Fernandez-Checa. 2006. Mitochondrial glutathione: hepatocellular survival-death switch. J. Gastroenterol. Hepatol. 21:S3-S6.
17. Gazina, E. V., J. E. Fielding, B. Lin, and D. A. Anderson. 2000. Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses. J. Virol. 74:4721-4728.
18. Gilles, P. N., G. Fey, and F. V. Chisari. 1992. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 66:3955-3960.
19. Guidotti, L. G., K. Ando, M. V. Hobbs, T. Ishikawa, L. Runkel, R. D. Schreiber, and F. V. Chisari. 1994. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA 91:3764-3768.
20. Guidotti, L. G., and F. V. Chisari. 2000. Cytokine-mediated control of viral infections. Virology 273:221-227.
21. Guidotti, L. G., and F. V. Chisari. 1996. To kill or to cure: options in host defense against viral infection. Curr. Opin. Immunol. 8:478-483.
22. Guidotti, L. G., S. Guilhot, and F. V. Chisari. 1994. Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways. J. Virol. 68:1265-7120.
23. Guidotti, L. G., H. McClary, J. M. Loudis, and F. V. Chisari. 2000. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J. Exp. Med. 191:1247-1252.
24. Guidotti, L. G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829.
25. Guilhot, S., L. G. Guidotti, and F. V. Chisari. 1993. Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism. J. Virol. 67:7444-7449.
26. Guo, J. T., H. Zhou, C. Liu, C. Aldrich, J. Saputelli, T. Whitaker, M. I. Barrasa, W. S. Mason, and C. Seeger. 2000. Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J. Virol. 74:1495-1505.
27. Heise, T., L. G. Guidotti, and F. V. Chisari. 1999. La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA. J. Virol. 73:5767-5776.
28. Herbein, G., and W. A. O'Brien. 2000. Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc. Soc. Exp. Biol. Med. 223:241-257.
29. Hodgson, P. D., and T. I. Michalak. 2001. Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection. Hepatology 34:1049-1059.
30. Jilbert, A. R., and I. Kotlarski. 2000. Immune responses to duck hepatitis B virus infection. Dev. Comp. Immunol. 24:285-302.
31. Jilbert, A. R., T. T. Wu, J. M. England, P. M. Hall, N. Z. Carp, and A. P. O'Connell. 1992. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J. Virol. 66:1377-1388.
32. Kajino, K., A. R. Jilbert, J. Saputelli, C. E. Aldrich, J. Cullen, and W. Mason. 1994. Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J. Virol. 68:5792-5803.
33. Kakimi, K., T. E. Lane, S. Wieland, V. C. Asensio, I. L. Campbell, F. V. Chisari, and L. G. Guidotti. 2001. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J. Exp. Med. 194:1755-1766.
34. Kang, H. Y., S. Lee, S. G. Park, J. Yu, Y. Kim, and G. Jung. 2006. Phosphorylation of hepatitis B virus Cp at Ser87 facilitates core assembly. Biochem. J. 398:311-317.
35. Kann, M., A. Bischof, and W. H. Gerlich. 1997. In vitro model for the nuclear transport of the hepadnavirus genome. J. Virol. 71:1310-1316.
36. Kann, M., and W. H. Gerlich. 1994. Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus. J. Virol. 68:7993-8000.
37. Kann, M., B. Sodeik, A. Vlachou, W. H. Gerlich, and A. Helenius. 1999. Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J. Cell Biol. 145:45-55.
38. Kau, J.-H., and L.-P. Ting. 1998. Phosphorylation of the core protein of hepatitis B virus by a 46-kilodalton serine kinase. J. Virol. 72:3796-3803.
39. Khaiboullina, S. F., D. M. Netski, P. Krumpe, and S. C. St Jeor. 2000. Effects of tumor necrosis factor alpha on Sin Nombre virus infection in vitro. J. Virol. 74:11966-11971.
40. Kimura, K., K. Kakimi, S. Wieland, L. G. Guidotti, and F. V. Chisari. 2002. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J. Virol. 76:10702-10707.
41. Lan, Y. T., J. Li, W. Liao, and J. Ou. 1999. Roles of the three major phosphorylation sites of hepatitis B virus core protein in viral replication. Virology 259:342-348.
42. Lane, B. R., D. M. Markovitz, N. L. Woodford, R. Rochford, R. M. Strieter, and M. J. Coffey. 1999. TNF inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J. Immunol. 163:3653-3661.
43. Laroia, G., and R. J. Schneider. 2002. Alternate exon insertion controls selective ubiquitination and degradation of different AUF1 protein isoforms. Nucleic Acids Res. 30:3052-3058.
44. Lavanchy, D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 11:97-107.
45. Lenhoff, R. J., and J. Summers. 1994. Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes. J. Virol. 68:5706-5713.
46. Li, H., S. Park, B. Kilburn, M. A. Jelinek, A. Henschen-Edman, D. W. Aswad, M. R. Stallcup, and I. A. Laird-Offringa. 2002. Lipopolysaccharide- induced methylation of HuR, an mRNA-stabilizing protein, by CARM1. Coactivator-associated arginine methyltransferase. J. Biol. Chem. 277:44623-44630.
47. Liao, W., and J. H. Ou. 1995. Phosphorylation and nuclear localization of the hepatitis B virus core protein: significance of serine in the three repeated SPRRR motifs. J. Virol. 69:1025-1029.
48. Lingappa, J. R., R. L. Martin, M. L. Wong, D. Ganem, W. J. Welch, and V. R. Lingappa. 1994. A eukaryotic cytosolic chaperonin is associated with a high molecular weight intermediate in the assembly of hepatitis B virus capsid, a multimeric particle. J. Cell Biol. 125:99-111.
49. Lingappa, J. R., M. A. Newman, K. C. Klein, and J. E. Dooher. 2005. Comparing capsid assembly of primate lentiviruses and hepatitis B virus using cell-free systems. Virology 333:114-123.
50. Lu, M., B. Lohrengel, G. Hilken, T. Kemper, and M. Roggendorf. 2002. Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to deplete woodchuck hepatitis virus replication intermediates and RNAs in persistently infected woodchuck primary hepatocytes. J. Virol. 76:58-67.
51. Mandart, E., A. Kay, and F. Galibert. 1984. Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences. J. Virol. 49:782-792.
52. McClary, H., R. Koch, F. V. Chisari, and L. G. Guidotti. 2000. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J. Virol. 74:2255-2264.
53. Melegari, M., S. K. Wolf, and R. J. Schneider. 2005. Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression. J. Virol. 79:9810-9820.
54. Nakamura, I., J. T. Nupp, M. Cowlen, W. C. Hall, B. C. Tennant, J. L. Casey, J. L. Gerin, and P. J. Cote. 2001. Pathogenesis of experimental neonatal woodchuck hepatitis virus infection: chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis factor-alpha messenger RNAs. Hepatology 33:439-447.
55. Newman, M., F. M. Suk, M. Cajimat, P. K. Chua, and C. Shih. 2003. Stability and morphology comparisons of self-assembled virus-like particles from wild-type and mutant human hepatitis B virus capsid proteins. J. Virol. 77:12950-12960.
56. Penna, A., M. Artini, A. Cavalli, M. Levrero, A. Bertoletti, M. Pilli, F. V. Chisari, B. Rehermann, G. Del Prete, F. Fiaccadori, and C. Ferrari. 1996. Long-lasting memory T cell responses following self-limited acute hepatitis B. J. Clin. Investig. 98:1185-1194.
57. Perry, A. K., G. Chen, D. Zheng, H. Tang, and G. Cheng. 2005. The host type I interferon response to viral and bacterial infections. Cell Res. 15:407-422.
58. Phi Van, L. 1996. Transcriptional regulation of chicken lysozyme gene by NF-kB. Biochem. J. 313:39-44.
59. Pollack, J. R., and D. Ganem. 1993. An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation. J. Virol. 67:3254-3263.
60. Robek, M. D., S. F. Wieland, and F. V. Chisari. 2002. Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J. Virol. 76:3570-3574.
61. Rossol-Voth, R., S. Rossol, K. H. Schutt, S. Corridori, W. de Cian, and D. Falke. 1991. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J. Gen. Virol. 72: 143-147.
62. Sarkar, B., J.-Y. Liu, and R. J. Schneider. 2003. Nuclear import and export functions in the different isoforms of the AUF1/heterogeneous nuclear ribonucleoprotein protein family. J. Biol. Chem. 278:20700-20707.
63. Schultz, U., and F. V. Chisari. 1999. Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes. J. Virol. 73:3162-3168.
64. Schultz, U., J. Summers, P. Staeheli, and F. V. Chisari. 1999. Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha-treated hepatocytes. J. Virol. 73:5459-5465.
65. Seifer, M., and D. N. Standring. 1995. Assembly and antigenicity of hepatitis B virus core particles. Intervirology 38:47-62.
66. Singh, S., and A. Zlotnick. 2003. Observed hysteresis of virus capsid diassembly is implicit in kinetic models of assembly. J. Biol. Chem. 278:18249-18255.
67. Sohn, S.-Y., S.-B. Kim, J. Kim, and B.-Y. Ahn. 2006. Negative regulation of hepatitis B virus replication by cellular Hsp40/DnaJ proteins through destabilization of viral core and X proteins. J. Gen. Virol. 87:1883-1891.
68. Stray, S. J., P. Ceres, and A. Zlotnick. 2004. Zinc ions trigger conformational change and oligomerization of hepatitis B virus capsid protein. Biochemistry 43:9989-9998.
69. Tipples, G. A., M. M. Ma, K. P. Fischer, V. G. Bain, N. M. Kneteman, and D. L. Tyrrell. 1996. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24:714-717.
70. Zlotnick, A., P. Ceres, S. Singh, and J. M. Johnson. 2002. A small molecule inhibits and misdirects assembly of hepatitis B virus capsids. J. Virol. 76:4848-4854.
71. Zlotnick, A., N. Cheng, J. F. Conway, F. P. Booy, A. C. Steven, S. J. Stahl, and P. T. Wingfield. 1996. Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry 35:7412-7421.